Nebenwirkungen · Azilect
AZILECT 1 mg tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-113340 · Präparat HOS-093909
Hypertension Rasagiline selectively inhibits MAO-B and is not associated with increased tyramine sensitivity at the indicated dose (1 mg/day). In blinded placebo-controlled studies (monotherapy and adjunct) severe hypertension was not reported in any subjects in the rasagiline arm. In the post-marketing period, cases of elevated blood pressure, including rare serious cases of hypertensive crisis associated with ingestion of unknown amounts of tyramine-rich foods, have been reported in patients taking rasagiline. In post-marketing period, there was one case of elevated blood pressure in a patient using the ophthalmic vasoconstrictor tetrahydrozoline hydrochloride while taking rasagiline.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-04-08T15:00:00Z · SHA-256 5aca218191417820622c35e4d3518e059be3e9d90752c7aded0ac355eb0d2e23 · Passage ed0257845106724f982983f6a6bcf64b84a3ac2f37513a3129ee2d797c60fb1b · Zeichen 6799–7494 im Abschnitt